APEIRON CAPITAL Ltd Takes $2.38 Million Position in Synopsys, Inc. $SNPS

APEIRON CAPITAL Ltd purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS) during the first quarter, Holdings Channel reports. The institutional investor purchased 6,000 shares of the semiconductor company’s stock, valued at approximately $2,379,000. Synopsys makes up approximately 2.2% of APEIRON CAPITAL Ltd’s investment portfolio, making the stock its 11th biggest position.

Other large investors have also recently bought and sold shares of the company. Sankala Group LLC acquired a new stake in Synopsys during the 4th quarter worth about $25,000. Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Synopsys in the 4th quarter valued at about $28,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Synopsys in the 4th quarter valued at about $28,000. Atlas Capital Advisors Inc. purchased a new stake in shares of Synopsys in the fourth quarter worth approximately $32,000. Finally, Phillip James Consulting Co. purchased a new stake in shares of Synopsys in the fourth quarter worth approximately $36,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the stock. Wells Fargo & Company boosted their price objective on shares of Synopsys from $505.00 to $535.00 and gave the company an “equal weight” rating in a research report on Thursday, May 28th. Citigroup increased their target price on shares of Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Stifel Nicolaus lifted their target price on shares of Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Piper Sandler upgraded shares of Synopsys from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $450.00 to $550.00 in a report on Tuesday. Finally, Berenberg Bank set a $633.00 price target on shares of Synopsys in a research note on Wednesday, May 27th. Ten investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $570.06.

Synopsys Price Performance

Shares of SNPS opened at $454.34 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. The firm has a market cap of $87.00 billion, a PE ratio of 105.17, a PEG ratio of 2.67 and a beta of 1.22. The firm’s 50 day moving average price is $483.67 and its 200 day moving average price is $462.15. Synopsys, Inc. has a twelve month low of $376.18 and a twelve month high of $651.73.

Synopsys (NASDAQ:SNPS) last posted its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The company had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. During the same period in the previous year, the firm posted $3.67 earnings per share. The company’s revenue for the quarter was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, research analysts expect that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.

Insider Buying and Selling at Synopsys

In other news, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares in the company, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by insiders.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.